Abstract
Catheter-based renal denervation for the treatment of drug-resistant hypertension has been intensively investigated in recent years. To date, only limited data have been published using multi-electrode radiofrequency ablation systems that can deliver lesions with a pre-determined pattern. This study was designed to evaluate the safety and performance of the second generation EnligHTN™ Renal Denervation System. This first-in-human, prospective, multi-center, non-randomized study included 39 patients (62% male, mean age 63 years, and mean baseline office blood pressure 174/93 mmHg) with drug-resistant hypertension. The primary safety and performance objectives were to characterize, from baseline to 6 months post procedure, the rate of serious procedural and device related adverse events, as adjudicated by an independent Clinical Events Committee, and the reduction of office systolic blood pressure. Renal artery denervation, using the second generation EnligHTN multi-electrode system significantly reduced office blood pressure from baseline to 1, 3, 6, 12, 18 and 24 months by 19/7, 26/9, 25/7, 23/7, 25/8 and 27/9 mmHg, respectively (p ≤ 0.0005). No serious device or procedure related adverse events affecting the renal arteries or ...Continue Reading
Citations
Mar 8, 2018·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Christopher T BanekJohn W Osborn
Nov 9, 2018·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Atsushi SakaokaKenichi Sakakura
Apr 15, 2020·Nature Reviews. Cardiology·Lucas LauderFelix Mahfoud
Sep 4, 2020·Current Hypertension Reports·Bo LiangNing Gu
Sep 12, 2018·Physiological Research·M TáborskýL Kopkan
Mar 25, 2019·International Journal of Hypertension·Yang LiNaifeng Liu
Mar 19, 2019·Hypertension·Christopher T BanekJohn W Osborn
Mar 27, 2018·The Journal of Clinical Hypertension·Andrea DenegriIsabella Sudano
May 26, 2020·Current Problems in Cardiology·Oluwaseun A AkinseyeUzoma N Ibebuogu
Dec 31, 2019·Progress in Cardiovascular Diseases·Aashish GuptaJ Stephen Jenkins
Oct 29, 2020·Irish Journal of Medical Science·Sumeeyae HaribabuHaroon Zafar
Feb 17, 2021·The Journal of Clinical Hypertension·Marit D SolbuTerje K Steigen
May 1, 2021·Current Opinion in Cardiology·Tamunoinemi Bob-ManuelJose Tafur
Jun 7, 2021·Cardiovascular Diabetology·Bo LiangNing Gu
Jul 23, 2019·Heart, Lung & Circulation·Sara I Al RaisiPramesh Kovoor